Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

Pharmacokinetics of CPX-351 (cytarabine/daunorubicin HCl) liposome injection in the mouse.

Bayne WF, Mayer LD, Swenson CE.

J Pharm Sci. 2009 Jul;98(7):2540-8. doi: 10.1002/jps.21620.

PMID:
19009594
2.

Determination of pilocarpic acid in human plasma by capillary gas chromatography with mass-selective detection.

Birk KL, Dru JD, Hsieh JY, Demetriades JL, Matuszewski BK, Bayne WF, Woolf EJ, Cairns AM, Rogers JD, Musson DG.

J Chromatogr B Biomed Sci Appl. 1998 Nov 20;719(1-2):93-102.

PMID:
9869369
3.

Determination of the HMG-CoA reductase inhibitors simvastatin, lovastatin, and pravastatin in plasma by gas chromatography/chemical ionization mass spectrometry.

Morris MJ, Gilbert JD, Hsieh JY, Matuszewski BK, Ramjit HG, Bayne WF.

Biol Mass Spectrom. 1993 Jan;22(1):1-8.

PMID:
8431499
4.

High-performance liquid chromatographic method for the determination of finasteride in human plasma at therapeutic doses.

Constanzer ML, Matuszewski BK, Bayne WF.

J Chromatogr. 1991 May 3;566(1):127-34.

PMID:
1653258
5.
10.

A sensitive method for assay of a novel tricyclic compound using coulometric electrochemical detection.

Fisher AL, Bayne WF, Musson DG.

J Pharm Sci. 1989 Nov;78(11):971-4.

PMID:
2621585
11.
12.

The physiological disposition of lovastatin.

Duggan DE, Chen IW, Bayne WF, Halpin RA, Duncan CA, Schwartz MS, Stubbs RJ, Vickers S.

Drug Metab Dispos. 1989 Mar-Apr;17(2):166-73.

PMID:
2565206
13.
14.
15.

High-performance liquid chromatographic determination of enprofylline in human plasma.

Hsieh JY, Thornton TJ, Bayne WF.

J Chromatogr. 1988 Aug 19;430(1):175-9. No abstract available.

PMID:
3215954
16.
17.

Improved method for the determination of theophylline in plasma and urine using high-performance liquid chromatography.

Chiou R, Stubbs RJ, Bayne WF.

J Chromatogr. 1987 Nov 27;422:281-7. No abstract available.

PMID:
3437015
19.
20.

Determination of ivermectin in human plasma and milk by high-performance liquid chromatography with fluorescence detection.

Chiou R, Stubbs RJ, Bayne WF.

J Chromatogr. 1987 Apr 24;416(1):196-202. No abstract available.

PMID:
3597637
24.

Analysis of sulindac and metabolites in plasma and urine by high-performance liquid chromatography.

Stubbs RJ, Ng LL, Entwistle LA, Bayne WF.

J Chromatogr. 1987 Jan 23;413:171-80.

PMID:
3558666
25.

Determination of mevinolin and mevinolinic acid in plasma and bile by reversed-phase high-performance liquid chromatography.

Stubbs RJ, Schwartz M, Bayne WF.

J Chromatogr. 1986 Dec 19;383(2):438-43. No abstract available.

PMID:
3644824
26.

Improved method for the determination of indomethacin in plasma and urine by reversed-phase high-performance liquid chromatography.

Stubbs RJ, Schwartz MS, Chiou R, Entwistle LA, Bayne WF.

J Chromatogr. 1986 Dec 19;383(2):432-7. No abstract available.

PMID:
3558574
27.

High-performance liquid chromatographic determination of cilastatin in biological fluids.

Demetriades JL, Souder PR, Entwistle LA, Vincek WC, Musson DG, Bayne WF.

J Chromatogr. 1986 Oct 31;382:225-31.

PMID:
3465739
28.

Determination of chlorothiazide in urine using reversed-phase high-performance liquid chromatography with ultraviolet detection.

Hessey GA 2nd, Constanzer ML, Bayne WF.

J Chromatogr. 1986 Aug 2;380(2):450-4. No abstract available.

PMID:
3760076
29.

Determination of diflunisal in human plasma and urine by fast high-performance liquid chromatography.

Schwartz M, Chiou R, Stubbs RJ, Bayne WF.

J Chromatogr. 1986 Aug 2;380(2):420-4. No abstract available.

PMID:
3760071
30.

General method for assessing bioavailability of drugs undergoing reversible metabolism in a linear system.

Hwang SS, Bayne WF.

J Pharm Sci. 1986 Aug;75(8):820-1. No abstract available.

PMID:
3772758
31.

Determination of codeine in plasma and urine by reversed-phase high-performance liquid chromatography.

Stubbs RJ, Chiou R, Bayne WF.

J Chromatogr. 1986 Apr 25;377:447-53. No abstract available.

PMID:
3711241
32.

Determination of cimetidine in plasma and urine by high-performance liquid chromatography.

Chiou R, Stubbs RJ, Bayne WF.

J Chromatogr. 1986 Apr 25;377:441-6. No abstract available.

PMID:
3711240
33.
34.

Bioanalysis and disposition of alpha-fluoromethylhistidine, a new histidine decarboxylase inhibitor.

August TF, Musson DG, Hwang SS, Duggan DE, Hooke KF, Roman IJ, Ferguson RJ, Bayne WF.

J Pharm Sci. 1985 Aug;74(8):871-5.

PMID:
4032273
36.

Determination of cyclobenzaprine in plasma and urine using capillary gas chromatography with nitrogen-selective detection.

Constanzer ML, Vincek WC, Bayne WF.

J Chromatogr. 1985 May 3;339(2):414-8. No abstract available.

PMID:
4008581
37.

Amiloride: biological fluid analysis by reverse-phase HPLC.

Vincek WC, Hessey Ii GA, Constanzer ML, Bayne WF.

Pharm Res. 1985 May;2(3):143-5. doi: 10.1023/A:1016371618594.

PMID:
24272694
39.

Analytical method for the quantification of famotidine, an H2-receptor blocker, in plasma and urine.

Vincek WC, Constanzer ML, Hessey GA 2nd, Bayne WF.

J Chromatogr. 1985 Mar 22;338(2):438-43. No abstract available.

PMID:
2860117
40.
41.
44.

Influence of protein binding on the accumulation and depletion of drug from the skin.

Hwang SS, Bayne WF.

J Pharm Sci. 1984 May;73(5):710-2. No abstract available.

PMID:
6737253
45.

Dynamic method for estimating the extent of plasma protein binding in a dialysis experiment.

Hwang SS, Bayne WF.

J Pharm Sci. 1984 May;73(5):708-10. No abstract available.

PMID:
6737252
47.
49.

Time course and disposition of methazolamide in human plasma and red blood cells.

Bayne WF, Tao FT, Rogers G, Chu LC, Theeuwes F.

J Pharm Sci. 1981 Jan;70(1):75-81.

PMID:
6785411
50.

Acetazolamide binding to two carbonic anhydrase isoenzymes in human erythrocytes.

Bayne WF, Chu LC, Theeuwes F.

J Pharm Sci. 1979 Jul;68(7):912-3.

PMID:
110919

Supplemental Content

Loading ...
Support Center